BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Transgene

TRANSGENE is a leading integrated gene therapy company, dedicated to the discovery and development of gene delivery technologies and gene therapy products for the treatment of acquired and inherited diseases. The Company's proprietary technology platform consists of five vector families including three of viral origin - adenovirus, retrovirus, vaccinia virus - and two of non viral origin - cellular and synthetic vectors.


Contact Details:
11 rue de Molsheim
Strasbourg
F-67082
France
Tel:00 33 88 27 91 00
Fax:00 33 88 27 91 11
Email:
WWW:

www.transgene.fr/




Recent Publications by Transgene:

A vector-based minigene vaccine approach results in strong induction of T-cell responses specific of hepatitis C virus.
Multiepitope-based vaccines against hepatitis C virus (HCV) were designed...
18th July, 2008
TRANSGENE SA, Infectious Diseases Department, Site de l'AFSSA, 31 Avenue Vaccine. 2008 May 12;26(20):2471-81. Epub 2008 Apr 1.
DOI Direct Link
Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies.
For over 10 years, bone marrow-derived endothelial progenitor cells (EPCs)...
17th July, 2008
Center for Transgene Technology and Gene Therapy, Flanders Institute for Expert Rev Cardiovasc Ther. 2008 Jun;6(5):687-701.
DOI Direct Link
N-methyl-d-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low-density lipoprotein receptor-associated protein.
The effects of a synthetic apoE peptide, viz., residues 133-149...
8th July, 2008
W.M. Keck Center for Transgene Research, Department of Chemistry and Neuropharmacology. 2008 May 24;.
DOI Direct Link
Restoration of Plasma von Willebrand Factor Deficiency Is Sufficient to Correct Thrombus Formation After Gene Therapy for Severe von Willebrand Disease.
OBJECTIVE: Gene therapy for severe von Willebrand disease (vWD) seems an...
17th June, 2008
Laboratory for Thrombosis Research, K.U. Leuven Campus Kortrijk, Belgium; Arterioscler Thromb Vasc Biol. 2008 Jun 12;.
DOI Direct Link
A Missense Mutation in the Sodium Phosphate Co-transporter Slc34a1 Impairs Phosphate Homeostasis.
The sodium phosphate co-transporters Npt2a and Npt2c play important roles...
14th June, 2008
*W.M. Keck Center for Transgene Research and the Department of Chemistry J Am Soc Nephrol. 2008 Jun 11;.
DOI Direct Link

View more Transgene research publications.

BioNews Results for Transgene:

Appointment of Olivier Meyer as President and Chief Executive Officer of Bioxel Pharma
NewsBlaze:  Jul 16 2008 9:18PM Matching: transgene
Appointment of Olivier Meyer as President and Chief Executive Officer of Bioxel Pharma
Globe Investor:  Jul 16 2008 9:03PM Matching: transgene
Appointment of Olivier Meyer as President and Chief Executive Officer of Bioxel Pharma
Market Wire:  Jul 16 2008 9:00PM Matching: transgene
In vivo site-specific recombination using the -rec/six system
Bio Techniques:  Jul 11 2008 12:24PM Matching: transgene
Monsanto has to Accept Full Responsibility for Genetic Contamination
Global Research:  Jul 3 2008 3:14PM Matching: transgene
Promote your company here: BioNewsCast - Press Release Distribution

View more Transgene news.

Transgene Patents:

US Patent No.Title
6277601 Expression of a foamy virus envelope protein
6407178 Cationic polymers, complexes associating said cationic polymers with therapeutically active substances comprising at least a negative charge, in particular nucleic acids, and their use in gene therapy
6451256 Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicine
6475480 Use of adenoviral E4 reading frames to improve expression of a gene of interest
6479290 Chimeric adenoviral vectors

View more Transgene patents.

Transgene (TRGNY) Financial information Links from Barchart

TRGNY Quote from from Barchart.com
TRGNY Chart from from Barchart.com
TRGNY Profile from from Barchart.com
TRGNY Opinion from from Barchart.com

View more Transgene finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 109 individuals from Transgene using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 325 times since April 2007, the link to the organisation's website has been followed 68 times

Recent Search Terms used to find this page: transgene | transgene | transgene | trans gene biotech pharma | .

Search for more companies in Strasbourg

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Transgene
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.